{"id":"repevax-after-revaxis","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They work by introducing inactivated poliovirus antigens to the body, which triggers an immune response and provides immunity against poliovirus infection.","oneSentence":"REPEVAX and REVAXIS are inactivated poliovirus vaccines.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:48.345Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Protection against poliovirus types 1, 2, and 3"}]},"trialDetails":[{"nctId":"NCT00400309","phase":"PHASE3","title":"Safety of REPEVAX® Given One Month After REVAXIS®","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2006-06","conditions":"Healthy Adult","enrollment":500}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"REPEVAX® after REVAXIS®","genericName":"REPEVAX® after REVAXIS®","companyName":"Sanofi Pasteur, a Sanofi Company","companyId":"sanofi-pasteur-a-sanofi-company","modality":"Biologic","firstApprovalDate":"","aiSummary":"REPEVAX and REVAXIS are inactivated poliovirus vaccines. Used for Protection against poliovirus types 1, 2, and 3.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}